Código QR

Modulating CAR-T cell exhaustion and fitness in acute myeloid leukemia: mechanistic metabolic and microenvironmental strategies

Chimeric antigen receptor (CAR) T-cell therapy has achieved transformative outcomes in B-cell malignancies but remains limited in acute myeloid leukemia (AML), where antigenic heterogeneity, a suppressive myeloid-driven microenvironment, and a metabolically restrictive bone marrow niche collectively...

Descrición completa

Gardado en:
Detalles Bibliográficos
Autor Principal: Erden Atilla
Formato: Artigo
Idioma:Inglês
Publicado: Frontiers Media S.A. 2026-06-01
Series:Frontiers in Immunology
Assuntos:
Acceso en liña:https://www.frontiersin.org/articles/10.3389/fimmu.2026.1863485/full
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!